A ‘Game Changing’ Ruling for Whistleblowers
Pharmalot
June 3, 2011
At a recent national conference on qui tam litigation, a high-ranking Justice Department official stressed, “You would be hard pressed to find anyone who knows more about the False Claims Act than [Nolan Auerbach partner] Jeb White.” Reporters took note, for they have increasingly turned to Mr. White for his expertise on emerging False Claims Act trends. For example, leading industry publication Pharmalot turned to Mr. White when an influential court held that False Claims Act is violated when pharmaceutical and device makers pay kickbacks to physicians, even when a hospital or pharmacy was unaware that the resulting prescription was tainted by kickbacks. Mr. White maintained that this was a “game changing” decision for False Claims Act enforcement. Since then, government and qui tam attorneys have regularly cited this landmark court decision.